A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms
- Conditions
- Liver Neoplasms
- Interventions
- Other: CEUS guided biopsyOther: US guided biopsyDevice: Ultrasound
- Registration Number
- NCT02413437
- Lead Sponsor
- Peking University Cancer Hospital & Institute
- Brief Summary
The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound in percutaneous biopsy for liver occupied lesion.
- Detailed Description
The patients with liver neoplasms who need receive percutaneous biopsy were randomized into contrast-enhanced ultrasound(CEUS) group and conventional ultrasound(US) group.The aims include:
1. Comparison the diagnostic accuracy rate, specificity and sensitivity between CEUS and US group.
2. Comparison the diagnostic accuracy rate specificity and sensitivity between smaller(\<3cm) and larger(≥3cm) nodule group.
3. To explore operating strategy of contrast-enhanced ultrasound guided biopsy.
4. To evaluate economic efficiency of contrast-enhanced ultrasound guided biopsy compared with conventional ultrasound guided biopsy.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2088
- patients with liver occupied lesion who cannot be diagnosed by imaging examination or need pathological results
- severe anemia
- PLT<60000/mm3,prothrombin activityprothrombin time activity<70%
- women during menstruation, pregnancy, child birth and baby nursing period
- patients with severe mental disorder
- cardiopulmonary failure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description US guided biopsy Ultrasound Biopsy was operated under conventional ultrasound-guided CEUS guided biopsy CEUS guided biopsy Biopsy was operated under contrast-enhanced ultrasound-guided US guided biopsy US guided biopsy Biopsy was operated under conventional ultrasound-guided CEUS guided biopsy Ultrasound Biopsy was operated under contrast-enhanced ultrasound-guided
- Primary Outcome Measures
Name Time Method diagnostic accuracy 12 months diagnostic accuracy=(true positive+ ture negative)/number of parcitipants
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Beijing Cancer Hospital
🇨🇳Beijing, Beijing, China